trial
as of 2026-07-01CAE for Poorly Adherent Individuals With Schizophrenia
NCTId NCT06061952
at a glance
— · Completed
Enrollment 36 (actual)
Sponsored by University Hospitals Cleveland Medical Center
Primary completion 2025-08-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2024-01-16
Primary completion
2025-08-09
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
University Hospitals Cleveland Medical CenterLead Sponsor
Merck Sharp & Dohme LLCCollaborator
Investigators
1
Martha Sajatovic, MDPrincipal Investigator
Sites
1 total
Cleveland, United States
Facts & assertions
4 sourced
Enrollment
36
Phase
NA
Primary Completion Date
2025-08-09
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
company
indication
indication
indication
investigator
person